CLOT STIFFNESS MEASURED BY SEER SONORHEOMETRY AS A MARKER OF POOR PROGNOSIS IN HOSPITALIZED COVID-19 PATIENTS
Francisco José López-Jaime, Sandra Martín-Téllez, Alberto Doblas-Márquez, Ignacio Márquez-Gómez, José María Reguera-Iglesias, Manuel Isidro Muñoz-Pérez, Ihosvany Fernández-Bello, View ORCID ProfileAdrián Montaño
doi: https://doi.org/10.1101/2021.07.13.21260256
Francisco José López-Jaime
*Unidad de Hemostasia y Trombosis, Hospital Universitario Regional de Málaga, IBIMA, Málaga, Spain; (F.J.L.J.); (S.M.-T); (A.D.-M.); (M.I.M.-P.)
Sandra Martín-Téllez
*Unidad de Hemostasia y Trombosis, Hospital Universitario Regional de Málaga, IBIMA, Málaga, Spain; (F.J.L.J.); (S.M.-T); (A.D.-M.); (M.I.M.-P.)
Alberto Doblas-Márquez
*Unidad de Hemostasia y Trombosis, Hospital Universitario Regional de Málaga, IBIMA, Málaga, Spain; (F.J.L.J.); (S.M.-T); (A.D.-M.); (M.I.M.-P.)
Ignacio Márquez-Gómez
†Servicio de Enfermedades Infecciosas, Hospital Universitario Regional de Málaga, Málaga, Spain; (I.M.-G.); (J.M.R.-I)
José María Reguera-Iglesias
†Servicio de Enfermedades Infecciosas, Hospital Universitario Regional de Málaga, Málaga, Spain; (I.M.-G.); (J.M.R.-I)
Manuel Isidro Muñoz-Pérez
*Unidad de Hemostasia y Trombosis, Hospital Universitario Regional de Málaga, IBIMA, Málaga, Spain; (F.J.L.J.); (S.M.-T); (A.D.-M.); (M.I.M.-P.)
Ihosvany Fernández-Bello
‡Biopharm, Novo Nordisk, Madrid, Spain; (I.F.-B)
Adrián Montaño
*Unidad de Hemostasia y Trombosis, Hospital Universitario Regional de Málaga, IBIMA, Málaga, Spain; (F.J.L.J.); (S.M.-T); (A.D.-M.); (M.I.M.-P.)
Data Availability
No data in external datasets
Posted July 16, 2021.
CLOT STIFFNESS MEASURED BY SEER SONORHEOMETRY AS A MARKER OF POOR PROGNOSIS IN HOSPITALIZED COVID-19 PATIENTS
Francisco José López-Jaime, Sandra Martín-Téllez, Alberto Doblas-Márquez, Ignacio Márquez-Gómez, José María Reguera-Iglesias, Manuel Isidro Muñoz-Pérez, Ihosvany Fernández-Bello, Adrián Montaño
medRxiv 2021.07.13.21260256; doi: https://doi.org/10.1101/2021.07.13.21260256
CLOT STIFFNESS MEASURED BY SEER SONORHEOMETRY AS A MARKER OF POOR PROGNOSIS IN HOSPITALIZED COVID-19 PATIENTS
Francisco José López-Jaime, Sandra Martín-Téllez, Alberto Doblas-Márquez, Ignacio Márquez-Gómez, José María Reguera-Iglesias, Manuel Isidro Muñoz-Pérez, Ihosvany Fernández-Bello, Adrián Montaño
medRxiv 2021.07.13.21260256; doi: https://doi.org/10.1101/2021.07.13.21260256
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (678)
- Anesthesia (182)
- Cardiovascular Medicine (2678)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12310)
- Forensic Medicine (10)
- Gastroenterology (769)
- Genetic and Genomic Medicine (4158)
- Geriatric Medicine (390)
- Health Economics (685)
- Health Informatics (2694)
- Health Policy (1010)
- Hematology (365)
- HIV/AIDS (861)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (444)
- Neurology (3931)
- Nursing (212)
- Nutrition (584)
- Oncology (2071)
- Ophthalmology (596)
- Orthopedics (243)
- Otolaryngology (307)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1131)
- Primary Care Research (461)
- Public and Global Health (6578)
- Radiology and Imaging (1420)
- Respiratory Medicine (876)
- Rheumatology (414)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (54)
- Transplantation (189)
- Urology (169)